MarketCap
Facebook
X
TelegramAlexion Pharmaceuticals, Inc. P/S Ratio 2011-2026 | ALXN
Annual P/S Ratio Alexion Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 5.53 | 4.49 | 6.54 | 7.71 | 9.3 | 12 | 16.3 | 20.4 | 16 | 17.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.4 | 4.49 | 11.6 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Aptorum Group Limited
APM
|
105 | $ 0.79 | -1.15 % | $ 4.31 M |  China |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K |  USA |
 |
AbCellera Biologics
ABCL
|
12.8 | $ 3.49 | 0.58 % | $ 1.04 B |  Canada |
 |
Frequency Therapeutics
FREQ
|
12.6 | - | - | $ 528 M | USA |
 |
argenx SE
ARGX
|
311 | $ 700.45 | -1.19 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | China |
 |
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.6 | 1.41 % | $ 8.66 B |  Australia |
 |
Grifols, S.A.
GRFS
|
1.71 | $ 7.81 | -2.01 % | $ 6.83 B |  Spain |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
Ascendis Pharma A/S
ASND
|
947 | $ 225.98 | -1.32 % | $ 5 B |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | USA |
 |
BioCardia
BCDA
|
18.6 | $ 1.26 | -0.79 % | $ 26.7 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Anika Therapeutics
ANIK
|
2.24 | $ 14.2 | -0.7 % | $ 208 M | USA |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | Canada |
 |
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | USA |
 |
BioNTech SE
BNTX
|
35.7 | $ 91.19 | 1.21 % | $ 27.2 B | Germany |
 |
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.44 | -1.37 % | $ 367 M | Britain |
 |
Arcturus Therapeutics Holdings
ARCT
|
2.65 | $ 6.68 | -4.57 % | $ 183 M |  Israel |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | Canada |
 |
AVEO Pharmaceuticals
AVEO
|
2.32 | - | - | $ 521 M | USA |
 |
Burford Capital Limited
BUR
|
6.35 | $ 7.92 | 1.67 % | $ 1.31 B | Britain |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
0.237 | $ 2.54 | -5.22 % | $ 16 M | USA |
 |
Certara
CERT
|
2.57 | $ 6.67 | 1.6 % | $ 1.07 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 3.6 | -4.0 % | $ 7.83 B | Israel |
 |
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | USA |